← Back to feedRead original →
VERIFIEDMint Markets·positive
Sun Pharma Q4 results 2026: Profit jumps 26% YoY to ₹2,714 crore; recommends final dividend of ₹5 for FY26
AI Summary
- ·Sun Pharma reported a 26% year-on-year jump in profit for Q4 FY26, reaching ₹2,714 crore.
- ·The company recommended a final dividend of ₹5 per share for FY26.
- ·The results cover the fourth quarter of the fiscal year 2026.